Observational studyJAMA network open2025

Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer.

Adrien Rousseau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.